Fluid Management in Decompensated Liver Cirrhosis

Primary Management Approach

The American Association for the Study of Liver Diseases recommends sodium restriction, not fluid restriction, as the cornerstone of ascites management in cirrhotic patients, with a recommended sodium intake of ≤5 g/day 1, 2, 3
Sodium restriction results in weight loss and fluid mobilization, while fluid restriction alone is ineffective, based on the physiologic principle that fluid passively follows sodium 1, 2, 3

Implement fluid restriction to 1000-1500 mL/day when serum sodium drops below 125-130 mmol/L, representing hypervolemic hyponatremia due to non-osmotic hypersecretion of vasopressin and impaired free water clearance 1, 2, 3, 4
The European Association for the Study of the Liver suggests that fluid restriction may prevent further sodium decline but rarely improves sodium levels significantly in patients with serum sodium <125-130 mmol/L 4

The American Association for the Study of Liver Diseases recommends diuretics, not fluid restriction, as the primary pharmacologic intervention for cirrhotic ascites, starting with spironolactone 50-100 mg/day and adding furosemide 20-40 mg/day as needed 1, 2, 3
Target weight loss of 0.5 kg/day in the absence of peripheral edema, and individualize weight loss based on patient condition in the presence of peripheral edema 1, 2, 3

Do not implement fluid restriction in normonatremic patients (sodium ≥135 mmol/L), as this is unnecessary and may worsen nutritional status without benefit, according to the American Association for the Study of Liver Diseases 1, 2, 3
Avoid confusing sodium restriction with fluid restriction, as sodium restriction (≤5 g/day) is mandatory for all cirrhotic patients with ascites, while fluid restriction is reserved only for those with significant hyponatremia 1, 2, 3

Protein supplementation of 1.2-1.5 g/kg/day is recommended to prevent malnutrition, according to the American Association for the Study of Liver Diseases 1, 2, 3
For large-volume paracentesis, administer 6-8 g albumin per liter of ascites drained to prevent post-paracentesis circulatory dysfunction, as recommended by the European Association for the Study of the Liver 1, 2, 3
Monitor for complications including spontaneous bacterial peritonitis and hepatorenal syndrome, which have significantly increased risk in hyponatremic patients (sodium <130 mmol/L), according to the Journal of Hepatology 4

The American Association for the Study of Liver Diseases recommends initiating combination diuretic therapy with spironolactone 100 mg daily plus furosemide 40 mg daily, along with sodium restriction to ≤2 g/day, for patients with decompensated cirrhosis and ascites 5, 6
Combination therapy with spironolactone and furosemide provides faster ascites control and maintains adequate serum potassium levels compared to monotherapy, and should be started immediately in patients with recurrent or persistent ascites/edema 5, 7
With large peripheral edema present, there is no limitation on daily weight loss, allowing more aggressive diuresis initially, but once edema resolves, target weight loss should not exceed 0.5 kg/day to prevent intravascular volume depletion 5, 7

The European Association for the Study of the Liver suggests that if inadequate response after 3-4 days, increase both diuretics proportionally, with maximum doses of spironolactone 400 mg/day and furosemide 160 mg/day 5, 7

Frequent laboratory surveillance, including serum sodium, potassium, and creatinine, should be performed at least twice weekly initially, with daily weights to assess diuretic response 5, 7

Protein supplementation at 1.2-1.5 g/kg/day should be provided to prevent malnutrition, which is common in cirrhotic patients with ascites 7
Large-volume paracentesis with albumin infusion at 6-8 g per liter of ascites removed may be necessary for patients with tense ascites, to prevent post-paracentesis circulatory dysfunction 5, 6, 7

Patients with MELD 22 and decompensated cirrhosis should be referred for liver transplant evaluation immediately, as MELD 22 indicates significant mortality risk and transplant candidacy 5, 6

Refractory ascites is defined as failure to respond to maximum diuretic doses after at least 1 week on salt-restricted diet, or development of diuretic-intractable complications, and options include serial large-volume paracentesis, TIPSS, or expedited transplant listing 6, 7